Skip to content

Survey of Dexmedetomidine Effect On Supraclavicular Block Duration

Adding of Dexmedetomidine to Lidocaine in Supraclavicular Block undr ultrasound guid On Upper Limb Fracture Surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201607276280N9
Enrollment
60
Registered
2016-09-09
Start date
2016-08-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper limb fracture. Fracture of shafts of both ulna and radius

Interventions

Intervention 1: Dexmedetomidine Adding Lidocaine in Supraclavicular block. Intervention 2: Isotonic Salin Adding Lidocaine in Supraclavicular Block.
Treatment - Drugs
Dexmedetomidine Adding Lidocaine in Supraclavicular block
Isotonic Salin Adding Lidocaine in Supraclavicular Block

Sponsors

Vice Chancellor For Research of Guilan University OfMedical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:the patients between 18-60 years old;ASA class 1-2 ; radial and ulnar fracture surgery. Exclusion criteria: Patients on adrenoreceptor agonist ;or antagonist therapy; known hypersensitivity to local anaesthetic drugs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Duration of Motor and Sensory Blockade. Timepoint: Every 5minutes until 15 minutes then every 15minutes until one houre and then every 30minutes until patient undemand analgesia. Method of measurement: Numerical Rating Scale Questionare.

Secondary

MeasureTime frame
Blood Pressure,Heart Rate,Nausea and Vomiting . Timepoint: Every 5minutes until 15 minutes then every 15minutes until one houre and then every 30minutes until the sensory and motor block has completely worn off. Method of measurement: questionare ,heart rate ,blood pressure ,nausea and vomiting .;Heart rate. Timepoint: ?? 5????? ?? 15 ????? ??? ?? 15 ????? ?? ?????? ? ?????? ?? ?? 30????? ?? ????? ???? ???? ??? ? ?????. Method of measurement: ECG monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Haghighi

Guilan University Medical Sciences

manesthesist@gmail.com+98 13133323970

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026